Alnylam (ALNY) Higher on News of Possible Drug Partner
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Join SI Premium – FREE
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) is moving higher on reports from Bloomberg the company is in talks with "more than one" partner to help develop its injectable high cholesterol drug.
Shares are up 1.2 percent.
Shares are up 1.2 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $410 at Truist Securities
- GSK halts camlipixant development for chronic cough after mixed results
- Alnylam advances Alzheimer's drug trials, reports mivelsiran safety data
Create E-mail Alert Related Categories
FDA, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
